Canaccord Genuity reiterates a 'Buy' on Integra LifeSciences (NASDAQ: IART) price target cut from $63 to $53.

Canaccord analyst, William ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE